China Team Transplants 2 Pig Kidneys and Whole Liver Into 53-Year-Old, a Double First
Updated
Updated · Colombia One · Jun 5
China Team Transplants 2 Pig Kidneys and Whole Liver Into 53-Year-Old, a Double First
3 articles · Updated · Colombia One · Jun 5
Summary
Nearly five days after surgery in Nanning, two kidneys and a whole liver from one genetically modified pig were still functioning in a 53-year-old brain-dead man without immediate hyperacute rejection.
Six gene edits underpinned the procedure: researchers added three human genes to limit clotting and removed three pig genes to reduce immune attack; the liver produced bile within 19 hours and kidney waste markers returned to normal.
Around 36 hours in, doctors detected early rejection signs, including human cells gradually replacing pig cells, but monitoring stopped at the family’s preapproved five-day limit rather than organ failure.
The Guangxi operation is the first reported transplant of two pig kidneys plus a whole pig liver into one human recipient, extending a fast-moving xenotransplant field now pushing toward regulated trials in living patients.
If pig organs become common, who decides which patients get a human organ versus an animal one?
Beyond rejection, could pig organs transfer hidden viruses and trigger the next pandemic?
This breakthrough saved a life for five days, but can science ever defeat long-term rejection?
China Achieves World’s First Multi-Organ Pig-to-Human Transplant: Scientific Breakthrough and Global Implications for Organ Shortage
Overview
In June 2026, Chinese researchers made a major breakthrough by transplanting two kidneys and a whole liver from a genetically modified pig into a brain-dead man. This complex procedure marks a crucial step in xenotransplantation, showing that multiple pig organs can function in a human body, even if only for a short time. The success highlights the potential to address the global shortage of donor organs. However, multi-organ transplants are much more challenging than single-organ ones, requiring longer surgeries and posing higher risks, especially since recipients are often more seriously ill. This achievement demonstrates both the promise and the challenges ahead for future organ transplants.